echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Newly discovered inhibitor for the treatment of B-cell lymphoma

    Newly discovered inhibitor for the treatment of B-cell lymphoma

    • Last Update: 2021-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Image: Evaluation of the anti-tumor efficacy of IHMT-EZH2-115 in a xenograft mouse model

    Recently, researchers led by Professor Liu Qingsong, Hefei Institute of Material Science, Chinese Academy of Sciences, discovered an effective selective zeste homolog 2 (EZH2) enhancer inhibitor ihht-EZH2-115 for the treatment of b-cell lymphoma
    .

    EZH2 is the enzyme subunit of polycomb inhibition complex 2
    .


    As a therapeutic target for the treatment of cancer, it has been extensively studied


    In this study, the researchers started with EPZ6438, which showed anti-b-cell lymphoma effects in preclinical models.
    Under the guidance of computer-aided drug design, the researchers used focused medicinal chemistry methods to obtain IHMT-EZH2-115
    .

    Biochemical analysis showed that IHMT-EZH2-115 had a strong inhibitory effect on EZH2 wild type and mutant type
    .


    At the same time, it shows high selectivity for a wide range of histone methyltransferases


    In vivo, IHMT-EZH2-115 showed good oral pharmacokinetic characteristics in two mouse models of diffuse large b-cell lymphoma with EZH2 mutations, Pfeiffer (EZH2 A677G) and karpas422 (EZH2 Y641N), and showed Dose-dependent anti-tumor effect


    These results indicate that IHMT-EZH2-115 may be a potential candidate gene for clinical development of EZH2 mutation-driven tumors


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.